BSE filing, NSE: WAKEFIT. Summary written from the filing by ALFA Finder's alert engine.
Wakefit Innovations Ltd: key numbers
- Share price
- ₹138.01
- Market cap
- ₹4,577 Cr
- Revenue (annual)
- ₹1,489 Cr
- Net profit (annual)
- ₹189.2 Cr
- P/E (TTM)
- 23.7×Sector 35.2×
- Promoter holding
- 37.07%+0.19% QoQ
- FII holding
- 14.36%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Wakefit Innovations Ltd
All →Wakefit Innovations Other Announcement
Wakefit Innovations Ltd has submitted the quarterly certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the period ended September 30, 2026.
Wakefit Innovations Employee Stock Options
Wakefit Innovations Limited has granted 2,25,442 employee stock options under its ESOP-2019 plan. These options are exercisable into equity shares at a price of Rs. 1 each.
Wakefit Innovations Management Change
Mr. Kunal Chandel, Senior Manager - Legal and Senior Management Personnel, has resigned from Wakefit Innovations Limited, effective from the close of business on September 24, 2026.
Wakefit Innovations Annual General Meeting
Wakefit Innovations Limited held its 10th Annual General Meeting on September 09, 2026, through video conferencing to discuss and adopt financial matters.
Wakefit Innovations Employee Stock Options
Wakefit Innovations Limited has allotted 3,13,521 equity shares to employees following ESOP exercise. This increases the company's total paid-up equity share capital to 33,16,45,219 shares.
Wakefit Innovations Other Announcement
Wakefit Innovations Ltd is notifying shareholders with unregistered email addresses about how to access the Annual Report and AGM notice. This is a routine compliance communication.
Other board meeting date announcements
All →B.D. Industries (Pune) Board Meeting Date
B. D. Industries (Pune) will hold a board meeting on 14 November 2026 to consider unaudited standalone and consolidated half-year results. The agenda items are proposed only and no decision has been taken yet.
Health X Platform Board Meeting Date
Health X Platform will hold a board meeting on 14 November 2026 to approve quarterly results. Trading window stays closed until 48 hours after declaration.
Exato Technologies Board Meeting Date
Board meeting set for November 14, 2026 to approve half-year results and an ESOP scheme. Trading window closed from October 1.
Astal Laboratories Board Meeting Date
Astal Laboratories will hold a board meeting on 13 November 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended September 2026. The trading window stays closed until 48 hours after the meeting.
Brainbees Solutions Board Meeting Date
Brainbees Solutions will hold a board meeting on November 14, 2026 to approve September 2026 quarter and half-year results. Trading window stays closed until November 16.
Senco Gold Board Meeting Date
Senco Gold schedules a board meeting on 13 November 2026 to consider unaudited quarterly and half-year results. The trading window stays closed until 48 hours after declaration.